A Crunchbase News analysis of approximately 800 global seed financings between $5 million and $10 million this year reveals clustering in four key sectors: proptech, cancer therapeutics, space tech, and robotics. This mid-sized seed round range is seen as more representative of classic early-stage bets on unproven founders and technologies.

Proptech is attracting investment for companies focused on improving efficiency in planning and building, streamlining rental operations, and reducing energy consumption. Examples include Hint, Optiml, and Krane.

In cancer therapeutics, investors are backing companies developing treatments and diagnostics, with rounds in this range supporting innovative approaches. Notable companies include Rybodyn, Vivere Oncotherapies, and Valius Sciences.

Space and satellite tech, while often dominated by headlines like SpaceX's IPO, also sees significant activity in the mid-sized seed round space. Companies like Lux Aeterna, In Space Propulsion Technologies, and Constellation Space are developing reusable satellites and propulsion systems.

Robotics continues to be a strong area for seed funding, with ambitious ventures in areas such as "intimacy robots" and autonomous underwater robots securing rounds. Companies like Somnia Lab, Bubble Robotics, and Eternal.ag represent this trend. The analysis suggests that despite the prevalence of megarounds, investors still believe in the potential of smaller, modestly funded teams with ambitious goals.